Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the tumor ablation market?

The market size for tumor ablation has seen a swift growth in the last few years. Projected to surge from a value of $1.45 billion in 2024, to reach $1.62 billion in 2025, this market will experience a compound annual growth rate (CAGR) of 12.1%. Factors fueling the growth during the historical phase include the creation of better and more effective ablation methods, increased healthcare spending in emerging economies, a demographic trend towards aging populations, a growing cancer burden, and an escalating global prevalence of cancer.

What will be the tumor ablation market size in the future?

Predictions indicate a swift expansion of the tumor ablation market in the coming years, with its value projected to reach $2.54 billion in 2029, growing at a compound annual growth rate (CAGR) of 11.8%. This predicted surge over the forecast period can be associated with factors such as a rise in cancer cases, the proliferation of minimally invasive procedures, broadening applications, better cost-effectiveness in healthcare, and increased levels of awareness and education. Furthermore, key trends over the forecast period include technological innovation, ongoing advancements in ablation technologies, AI integration, an emphasis on outpatient settings, and patient-centered strategies.

Get your tumor ablation market report here!

https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report

What main drivers are fueling expansion in the tumor ablation market?

The tumor ablation market’s growth is anticipated to be fueled by the proliferation of minimally invasive procedures. These procedures, which require small or no incisions, are becoming increasingly popular due to their lesser recovery times, reduced incidence of complications and pain post-operation compared to conventional surgeries. Tumor ablation is employed in these procedures to eliminate cancerous tissues using methods like radiofrequency, microwave, or cryoablation. This limits damage to the surrounding healthy tissues and speeds up recovery. For example, in the fourth quarter of 2023, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported a placement of 415 da Vinci surgical systems (robotics using a minimally invasive surgical strategy), marking a 12% increase from 2022. As such, the rise of minimally invasive procedures is propelling the tumor ablation market’s growth.

What key areas define the segmentation of the global tumor ablation market?

The tumor ablation market covered in this report is segmented –

1) By Type: Thermal Ablation, Chemical Ablation

2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer

4) By End Users: Hospitals, Oncology Centers, Other End Users

Subsegments:

1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)

2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Chemotherapy-Based Ablation (Chemoembolization)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17283&type=smp

What are the top market players propelling the growth of the tumor ablation industry?

Major companies operating in the tumor ablation market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Bioventus LLC, Accuray Incorporated, AtriCure Inc., AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd.

What emerging trends are influencing the growth of the tumor ablation market?

Leading enterprises in the tumor ablation market are pioneering advanced products, like bone tumor ablation systems, to boost treatment effectiveness, enhance patient results, and widen the spectrum of treatable tumors. A system for ablating bone tumors is a sophisticated medical apparatus utilized for addressing bone tumors via minimally invasive methods. For example, in March 2024, Medtronic plc, a medical device company from Ireland, obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its OsteoCool 2.0 bone tumor ablation system. This advanced system is crafted to attend to painful bone metastases and benign bone tumors such as osteoid osteoma. The OsteoCool 2.0 has the capacity for the concurrent use of four internally cooled probes, granting doctors the ability to eliminate two vertebral bodies concurrently or create larger elimination zones in extra-spinal applications. It delivers 20W per channel, which is more than double the power of the Stryker OptaBlate bone tumor ablation system.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17283

Which regions are most influential in expanding the tumor ablation market?

North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Intratumoral Cancer Therapies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report

Tumor Infiltrating Lymphocytes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-infiltrating-lymphocytes-global-market-report

Solid Tumor Cancer Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: